Which of the following antineoplastic drugs has the lowest emetogenic potential?

Question

Quizplus · Accepted Answer

Rituximab is a monoclonal antibody that targets specific antigens on lymphoma cells, and has a lower incidence of causing chemotherapy-induced nausea and vomiting compared to other antineoplastic drugs such as cisplatin, dacarbazine, and idarubicin. Alemtuzumab is also a monoclonal antibody but has a higher incidence of causing nausea and vomiting compared to rituximab.

Which of the Following Antineoplastic Drugs Has the Lowest Emetogenic